Pharmaceutical companies that belong to the European Federation of Pharmaceutical Industries and Associations (EFPIA), and provide any kind of benefit to healthcare professionals based in Europe, have begun collecting data about those Transfer(s) of Value (TOV) in order to adhere to the voluntary EFPIA Disclosure Code. Starting in 2016, pharmaceutical companies will be reporting those TOV to the public. Pharmaceutical companies that employ physicians in the course of business, typically in ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the U.S. Pharma Spend Transparency Trend Spreads to Europe, you'll also gain access to exclusive premium content.

Already registered? here.